We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOPH icon
4826
SOPHiA GENETICS
SOPH
$649M
$8K ﹤0.01%
+600
New +$8.85K
TAIT
4827
DELISTED
Taitron Components
TAIT
$8K ﹤0.01%
2,099
+658
+46% +$2.74K
TAYD icon
4828
Taylor Devices
TAYD
$172M
$8K ﹤0.01%
711
+94
+15% +$1.05K
THFF icon
4829
First Financial Corp
THFF
$970M
$8K ﹤0.01%
167
-278
-62% -$12.2K
TIGO icon
4830
Millicom
TIGO
$15.8B
$8K ﹤0.01%
249
-58
-19% -$1.92K
TUSK icon
4831
Mammoth Energy Services
TUSK
$158M
$8K ﹤0.01%
+4,418
New +$11.5K
UGL icon
4832
ProShares Ultra Gold
UGL
$792M
$8K ﹤0.01%
536
+36
+7% +$522
VLN icon
4833
Valens Semiconductor
VLN
$210M
$8K ﹤0.01%
979
+879
+879% +$7.41K
YARW
4834
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
$8K ﹤0.01%
9
+3
+50% +$3.22K
YCBD icon
4835
cbdMD
YCBD
$5.93M
$8K ﹤0.01%
21
+4
+24% +$2.33K
TRAW icon
4836
Traws Pharma
TRAW
$8.12M
$8K ﹤0.01%
124
-110
-47% -$8.85K
VIVS
4837
VivoSim Labs
VIVS
$1.15M
$8K ﹤0.01%
174
-366
-68% -$23.5K
DPCSU
4838
DELISTED
DP Cap Acquisition Corp I Unit
DPCSU
$8K ﹤0.01%
+777
New +$7.84K
SDPI
4839
DELISTED
Superior Drilling Products Inc.
SDPI
$8K ﹤0.01%
11,600
+7,855
+210% +$8.24K
BTEC
4840
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
$8K ﹤0.01%
+164
New +$8.46K
AMJ
4841
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$8K ﹤0.01%
445
+294
+195% +$5.44K
TRVN
4842
DELISTED
Trevena, Inc.
TRVN
$8K ﹤0.01%
23
+7
+44% +$3.88K
CLAYU
4843
DELISTED
Chavant Capital Acquisition Corp. Unit
CLAYU
$8K ﹤0.01%
763
FRTX
4844
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$8K ﹤0.01%
824
+619
+302% +$11.1K
CCVI.U
4845
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
$8K ﹤0.01%
852
+385
+82% +$3.87K
SCU
4846
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$8K ﹤0.01%
370
-268
-42% -$6.12K
MDNA
4847
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$8K ﹤0.01%
4,872
+4,672
+2,336% +$9.69K
GTH
4848
DELISTED
Genetron Holdings Limited ADS
GTH
$8K ﹤0.01%
411
-789
-66% -$26.2K
EMAN
4849
DELISTED
eMagin Corporation
EMAN
$8K ﹤0.01%
6,088
+3,631
+148% +$7.26K
AXLA
4850
DELISTED
Axcella Health Inc. Common Stock
AXLA
$8K ﹤0.01%
144
+108
+300% +$7.58K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.